Interpatient Variability in Dexmedetomidine Response: A Survey of the Literature

by Samantha F. Holliday, Sandra L. Kane-Gill, Philip E. Empey, Mitchell S. Buckley, Pamela L. Smithburger
Published 2014-01-01

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available.

by Matthias Samwald, Hong Xu, Kathrin Blagec, Philip E Empey, Daniel C Malone, Seid Mussa Ahmed, Patrick Ryan, Sebastian Hofer, Richard D Boyce
Published 2016-01-01

A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension

by James C. Coons, Karryn Crisamore, Solomon Adams, Ashley Modany, Marc A. Simon, Wenchen Zhao, Imam H. Shaik, Raman Venkataramanan, Philip E. Empey
Published 2021-04-01

Dexmedetomidine Reduces Shivering during Mild Hypothermia in Waking Subjects.

by Clifton W Callaway, Jonathan Elmer, Francis X Guyette, Bradley J Molyneaux, Kacey B Anderson, Philip E Empey, Stacy J Gerstel, Kate Holquist, Melissa J Repine, Jon C Rittenberger
Published 2015-01-01

Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children.

by Robert S B Clark, Philip E Empey, Hülya Bayır, Bedda L Rosario, Samuel M Poloyac, Patrick M Kochanek, Thomas D Nolin, Alicia K Au, Christopher M Horvat, Stephen R Wisniewski, Michael J Bell
Published 2017-01-01

Multi-Center Pre-clinical Consortia to Enhance Translation of Therapies and Biomarkers for Traumatic Brain Injury: Operation Brain Trauma Therapy and Beyond

by Patrick M. Kochanek, C. Edward Dixon, Stefania Mondello, Stefania Mondello, Kevin K. K. Wang, Audrey Lafrenaye, Helen M. Bramlett, W. Dalton Dietrich, Ronald L. Hayes, Deborah A. Shear, Janice S. Gilsdorf, Michael Catania, Samuel M. Poloyac, Philip E. Empey, Travis C. Jackson, John T. Povlishock
Published 2018-08-01